Outlook Therapeutics received notice that the Food and Drug Administration can't approve its biologics license application for a drug designed to treat macular degeneration. The Iselin, N.J., ...

Over the past year, we’ve reported on countless problems with Microsoft’s Outlook apps, and they’re still coming. This time, it’s about difficulties opening the new Outlook app in Windows, something ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. In this episode, Thomas Betts chats with ...

Several Outlook users, on different forums, have reported encountering the error “OST file cannot be opened,” when trying to open the application or sending ...

Many users open the new Outlook and prefer the classic interface because it feels faster and supports familiar tools. Switching back takes just a few steps and restores the layout most people rely on ...

If your New Outlook starts in a browser tab rather than opening in a desktop window, leaving only a tiny envelope icon or “stub” window, you’re not alone. This is a common issue caused by local cache ...

ISELIN, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (OTLK) (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the ...

If Outlook opens in a browser instead of the app, execute the solutions given below. Change the default app in Windows settings Set Outlook as the default client for all extensions Change the default ...

ISELIN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (OTLK) (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Outlook Therapeutics ( (OTLK)) just ...